Scientists track kidney disease progression in rare genetic disorder
NCT ID NCT01022957
First seen Nov 20, 2025 · Last updated Jun 23, 2026 · Updated 26 times
Summary
This study followed 150 people with nephronophthisis, a rare genetic kidney disease, to see how kidney and other organ damage progresses over time. Researchers looked at patients with specific gene mutations to better understand the disease's long-term effects. The goal was to improve care and help families anticipate complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHRONOPHTHISIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Necker
Paris, 75015, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors predict and manage complications of nephronophthisis more effectively.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new therapy, so it cannot directly lead to a cure or symptom relief.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.